GATA4 and cardiac hypertrophy: Researches suggest transcription of p300 is controlled by myocyte-specific enhancer factor 2 (MEF2) and GATA4 (zinc-finger transcription factor, indicating cardiac hypertrophy, and increasing DNA accessibility), and this transcript control process is critical for cardiac development (24, 25) and heart failure (26–28).